These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 17968881)
41. Utility of in situ demonstration of 1p loss and p53 overexpression in pathologic diagnosis of oligodendroglial tumors. Hirose T; Ishizawa K; Shimada S Neuropathology; 2010 Dec; 30(6):586-96. PubMed ID: 20408960 [TBL] [Abstract][Full Text] [Related]
42. Losses of chromosomes 1p and 19q are rare in pediatric oligodendrogliomas. Kreiger PA; Okada Y; Simon S; Rorke LB; Louis DN; Golden JA Acta Neuropathol; 2005 Apr; 109(4):387-92. PubMed ID: 15739101 [TBL] [Abstract][Full Text] [Related]
43. TP53 codon 72 polymorphism, p53 expression, and 1p/19q status in oligodendroglial tumors. Idbaih A; Boisselier B; Marie Y; El Hallani S; Sanson M; Crinière E; Rodero M; Carpentier C; Paris S; Laigle-Donadey F; Ducray F; Hoang-Xuan K; Delattre JY Cancer Genet Cytogenet; 2007 Sep; 177(2):103-7. PubMed ID: 17854663 [TBL] [Abstract][Full Text] [Related]
44. [Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice]. Fontaine D; Vandenbos F; Lebrun C; Paquis V; Frenay M Rev Neurol (Paris); 2008; 164(6-7):595-604. PubMed ID: 18565359 [TBL] [Abstract][Full Text] [Related]
45. Magnetic resonance imaging of pilocytic astrocytomas: usefulness of the minimum apparent diffusion coefficient (ADC) value for differentiation from high-grade gliomas. Murakami R; Hirai T; Kitajima M; Fukuoka H; Toya R; Nakamura H; Kuratsu J; Yamashita Y Acta Radiol; 2008 May; 49(4):462-7. PubMed ID: 18415792 [TBL] [Abstract][Full Text] [Related]
46. High rate of deletion of chromosomes 1p and 19q in insular oligodendroglial tumors. Wu A; Aldape K; Lang FF J Neurooncol; 2010 Aug; 99(1):57-64. PubMed ID: 20035368 [TBL] [Abstract][Full Text] [Related]
47. Glioneuronal tumor with neuropil-like islands (GTNI): a report of 8 cases with chromosome 1p/19q deletion analysis. Barbashina V; Salazar P; Ladanyi M; Rosenblum MK; Edgar MA Am J Surg Pathol; 2007 Aug; 31(8):1196-202. PubMed ID: 17667543 [TBL] [Abstract][Full Text] [Related]
48. Hypermethylation and transcriptional downregulation of the CITED4 gene at 1p34.2 in oligodendroglial tumours with allelic losses on 1p and 19q. Tews B; Roerig P; Hartmann C; Hahn M; Felsberg J; Blaschke B; Sabel M; Kunitz A; Toedt G; Neben K; Benner A; von Deimling A; Reifenberger G; Lichter P Oncogene; 2007 Jul; 26(34):5010-6. PubMed ID: 17311001 [TBL] [Abstract][Full Text] [Related]
49. Gene expression profiles associated with treatment response in oligodendrogliomas. French PJ; Swagemakers SM; Nagel JH; Kouwenhoven MC; Brouwer E; van der Spek P; Luider TM; Kros JM; van den Bent MJ; Sillevis Smitt PA Cancer Res; 2005 Dec; 65(24):11335-44. PubMed ID: 16357140 [TBL] [Abstract][Full Text] [Related]
50. [The oligodendroglioma: the value of histologic and genetic diagnosis in predicting sensitivity to chemotherapy]. Kros JM Ned Tijdschr Geneeskd; 2005 Jun; 149(25):1379-85. PubMed ID: 15997690 [TBL] [Abstract][Full Text] [Related]
51. Molecular imaging of 1p/19q deletion in oligodendroglial tumours with 11C-methionine positron emission tomography. Iwadate Y; Shinozaki N; Matsutani T; Uchino Y; Saeki N J Neurol Neurosurg Psychiatry; 2016 Sep; 87(9):1016-21. PubMed ID: 26848169 [TBL] [Abstract][Full Text] [Related]
53. Characterization of low-grade gliomas using RGB color maps derived from ADC histograms. Khayal IS; Nelson SJ J Magn Reson Imaging; 2009 Jul; 30(1):209-13. PubMed ID: 19557741 [TBL] [Abstract][Full Text] [Related]
54. [Correlation between magnetic resonance diffusion weighted imaging and cell density in astrocytoma]. Chen J; Xia J; Zhou YC; Xia LM; Zhu WZ; Zou ML; Feng DY; Wang CY Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):309-11. PubMed ID: 15996330 [TBL] [Abstract][Full Text] [Related]
56. Can the apparent diffusion coefficient be used as a noninvasive parameter to distinguish tumor tissue from peritumoral tissue in cerebral gliomas? Pauleit D; Langen KJ; Floeth F; Hautzel H; Riemenschneider MJ; Reifenberger G; Shah NJ; Müller HW J Magn Reson Imaging; 2004 Nov; 20(5):758-64. PubMed ID: 15503327 [TBL] [Abstract][Full Text] [Related]
57. [Influence of molecular-genetic factors on prognosis in patients with oligodendroglial tumors]. Absaliamova OV; Korshunov AG; Loshakov VA; Kobiakov GL; Golanov AV; Urakov SV; Amanov RD; Lichinitser MR Zh Vopr Neirokhir Im N N Burdenko; 2009; (1):17-23; discussion 23-4. PubMed ID: 19507310 [TBL] [Abstract][Full Text] [Related]
58. Oligodendroglioma with neurocytic differentiation and characteristic loss of heterozygosity on chromosomes 1p and 19q. Vajtai I; Arnold M; Vassella E Acta Neuropathol; 2005 Nov; 110(5):520-2. PubMed ID: 16222523 [No Abstract] [Full Text] [Related]
59. [Application of apparent diffusion coefficient and fractional anisotropy in identification of tumor component and grading of brain astrocytoma]. Li M; Jia ZZ; Gu HM; Zhou XJ; Tang LM Zhonghua Yi Xue Za Zhi; 2008 Dec; 88(47):3352-5. PubMed ID: 19257968 [TBL] [Abstract][Full Text] [Related]
60. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors. Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]